220 related articles for article (PubMed ID: 9615202)
1. T1 and T2 bladder cancer: selecting optimal therapy.
Soloway MS
Eur Urol; 1998; 33 Suppl 4():16-7. PubMed ID: 9615202
[No Abstract] [Full Text] [Related]
2. The optimal management of T1G3 bladder cancer.
Emiliozzi P; Pansadoro A; Pansadoro V
BJU Int; 2008 Nov; 102(9 Pt B):1265-73. PubMed ID: 19035891
[No Abstract] [Full Text] [Related]
3. T1G3: What to do?
Mandressi A
Arch Ital Urol Androl; 1996 Feb; 68(1):5-7. PubMed ID: 8664922
[No Abstract] [Full Text] [Related]
4. Current problems and needs in the treatment of pT1 G3 bladder carcinoma.
Martínez Portillo FJ; Alken P
Int Urol Nephrol; 2002; 33(1):29-40. PubMed ID: 12090335
[No Abstract] [Full Text] [Related]
5. Contemporary management of stage T1 transitional cell carcinoma of the bladder.
Sataa S; Yassine N; Ghassen HH; Imed BS; Mohamed C; Maher C; Ali H
Tunis Med; 2005 Dec; 83 Suppl 12():87-9. PubMed ID: 16430077
[No Abstract] [Full Text] [Related]
6. The case for neoadjuvant chemotherapy and cystectomy for muscle invasive bladder cancer.
deVere White RW; Katz MH; Steinberg GD
J Urol; 2009 May; 181(5):1994-7. PubMed ID: 19286209
[No Abstract] [Full Text] [Related]
7. Neo-adjuvant and adjuvant chemotherapy of bladder cancer: Is there a role?
Sternberg CN
Ann Oncol; 2002; 13 Suppl 4():273-9. PubMed ID: 12401701
[No Abstract] [Full Text] [Related]
8. T1G3 bladder cancer--the case for TUR and BCG.
Miller K
Front Radiat Ther Oncol; 2002; 36():147-50. PubMed ID: 11842744
[No Abstract] [Full Text] [Related]
9. Intravesical bacillus Calmette-Guerin therapy for stage T1 grade 3 transitional cell carcinoma of the bladder: recurrence, progression and survival in a study of 57 patients.
Peyromaure M; Guerin F; Amsellem-Ouazana D; Saighi D; Debre B; Zerbib M
J Urol; 2003 Jun; 169(6):2110-2. PubMed ID: 12771729
[TBL] [Abstract][Full Text] [Related]
10. Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update.
Hall MC; Chang SS; Dalbagni G; Pruthi RS; Seigne JD; Skinner EC; Wolf JS; Schellhammer PF
J Urol; 2007 Dec; 178(6):2314-30. PubMed ID: 17993339
[No Abstract] [Full Text] [Related]
11. Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer.
Koie T; Ohyama C; Hosogoe S; Yamamoto H; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y; Yoneyama T; Tobisawa Y; Mori K
Int Urol Nephrol; 2015 Sep; 47(9):1509-14. PubMed ID: 26149637
[TBL] [Abstract][Full Text] [Related]
12. Impact of Adjuvant Intravesical Bacillus Calmette-Guérin Treatment on Patients with High-Grade T1 Bladder Cancer.
Novotny V; Froehner M; Ollig J; Koch R; Zastrow S; Wirth MP
Urol Int; 2016; 96(2):136-41. PubMed ID: 26789626
[TBL] [Abstract][Full Text] [Related]
13. The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary?
Wo JY; Shipley WU; Dahl DM; Coen JJ; Heney NM; Kaufman DS; Zietman AL
BJU Int; 2009 Jul; 104(2):179-83. PubMed ID: 19154448
[TBL] [Abstract][Full Text] [Related]
14. Editorial: Bladder cancer. How can we make a difference?
Soloway MS
J Urol; 2003 Nov; 170(5):1781-2. PubMed ID: 14532775
[No Abstract] [Full Text] [Related]
15. Management of high-risk non-muscle invasive bladder cancer.
Brausi M; Olaru V
Minerva Urol Nefrol; 2012 Dec; 64(4):255-60. PubMed ID: 23288212
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic strategies for organ-confined and non-organ-confined bladder cancer after radical cystectomy.
Marchioni M; Nazzani S; Preisser F; Bandini M; Karakiewicz PI
Expert Rev Anticancer Ther; 2018 Apr; 18(4):377-387. PubMed ID: 29429376
[TBL] [Abstract][Full Text] [Related]
17. [Bladder carcinoma 1: Radical cystectomy, neoadjuvant and adjuvant therapy modalities].
Lampel A; Thüroff JW
Urologe A; 1998 Jan; 37(1):93-101. PubMed ID: 9540194
[No Abstract] [Full Text] [Related]
18. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
[TBL] [Abstract][Full Text] [Related]
19. [Usefulness of radiotherapy in the treatment of infiltrating bladder cancer].
Escudero Barrilero A
Arch Esp Urol; 1990; 43 Suppl 2():165-84. PubMed ID: 1710884
[No Abstract] [Full Text] [Related]
20. The role of combined method in organ-sparing treatment of muscle-invasive bladder cancer recurrences.
Startsev VY
Arch Ital Urol Androl; 2002 Jun; 74(2):54-6. PubMed ID: 12161935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
